Streetbeat News

Earnings

WPM

Wheaton Precious Metals (NYSE:WPM) reported Q4 earnings, beating estimates with an EPS of $0.363 against an expected $0.33, and revenue increased by $77.42 million year-over-year. Despite missing EPS estimates last quarter, the share price increased by 0.0% the following day. The company has shown varied performance over the past quarters in terms of EPS and revenue.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:20 pm

LRMR

Larimar Therapeutics (NASDAQ:LRMR) reported Q4 earnings with an EPS of $-0.3, missing estimates by -20.0%. Revenue remained unchanged from the previous year. The company had previously beaten EPS estimates last quarter, leading to a 14% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:15 pm

VGZ

Vista Gold (AMEX:VGZ) reported a Q4 EPS of $(0.01), consistent with the previous year's results. The company has shown no revenue for the entire year, with a net loss fluctuating each quarter but remaining in the negative.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 9:10 pm

WPM

Wheaton Precious Metals (NYSE:WPM) reported Q4 adjusted EPS of $0.36, surpassing the $0.33 estimate, and sales of $313.47M, exceeding the $296.46M estimate. This represents a significant increase over the previous year's figures.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:10 pm

ALTG

Alta Equipment Group has released its financial guidance for FY24, expecting to report an Adjusted EBITDA between $207.5M and $217.5M.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:06 pm

CTSO

CytoSorbents (NASDAQ:CTSO) reported Q4 earnings with an EPS of $-0.12, beating estimates by 14% but with a revenue decrease of $691k from the previous year. Despite missing EPS estimates in Q3 2023, the share price increased by 1% the following day. The company's past earnings performance shows a mixed trend in meeting EPS estimates and fluctuating revenues.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:05 pm

IMAB

I-Mab reported a significant improvement in its financial performance for FY23, with EPS improving to $(0.76) from $(1.63) YoY and revenue increasing to $3.9M from $(32.1M) YoY. The non-GAAP adjusted net loss decreased to $155.7 million from $309.7 million YoY, with per share and per ADS losses also reducing significantly.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:03 pm

CTSO

CytoSorbents (NASDAQ:CTSO) reported Q4 2023 GAAP EPS of $(0.12), beating the $(0.14) estimate, but missed sales estimates with $8.700M compared to the expected $9.285M. This represents a 7.36% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:00 pm

MNTK

Montauk Renewables (NASDAQ:MNTK) reported Q4 earnings with an EPS of $0.04, missing estimates by -43.0% and a revenue decrease of $2.84 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, notably leading to a 37.0% share price drop after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:00 pm